ProQR Therapeutics Ratios (2013-2025) | PRQR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
EBT Margin (Quarter)		-5,433.33%	-1,669.38%	-7,250.21%	-1,508.32%	-1,702.37%	-2,435.26%	-1,730.56%	-1,433.44%	-731.20%	-539.49%	-190.86%	-181.46%	-57.10%	-226.80%	-234.06%	-239.34%	-320.91%	-391.53%	-194.05%
EBIT Margin (Quarter)		-5,433.33%	-1,669.38%	-7,250.21%	-1,508.32%	-1,702.37%	-2,435.26%	-1,730.56%	-1,433.44%	-731.20%	-539.49%	-190.86%	-181.46%	-57.10%	-226.80%	-234.06%	-239.34%	-320.91%	-391.53%	-194.05%
EBITDA Margin (Quarter)		-6,540.74%	1,704.47%	7,565.69%	1,229.65%	1,375.70%	-2,787.71%	-1,730.56%	1,385.34%	-661.41%	420.07%	-190.86%	-167.80%	41.35%	220.79%	-234.06%	-231.25%	-336.94%	382.69%	-194.05%
Operating Margin (Quarter)		-5,433.33%	-1,669.38%	-7,250.21%	-1,508.32%	-1,702.37%	-2,435.26%	-1,730.56%	-1,433.44%	-731.20%	-539.49%	-190.86%	-181.46%	-57.10%	-226.80%	-234.06%	-239.34%	-320.91%	-391.53%	-194.05%
Net Margin (Quarter)		-6,537.86%	-1,725.57%	-7,623.85%	-1,248.58%	-1,473.12%	-2,864.62%	-1,846.81%	-1,397.25%	-663.32%	-441.24%	-150.30%	-172.09%	-42.70%	-220.79%	-213.70%	-231.25%	-336.94%	-382.69%	-167.32%
FCF Margin (Quarter)		-4,085.19%	-903.90%	1,677.82%	-1,789.65%	-1,571.29%	-1,857.25%	-2,154.72%
Efficiency
Assets Average (Quarter)	55.31B	55.35B	0.21B	0.24B	0.23B	0.20B	0.16B	0.15B	0.17B	0.17B	0.16B	0.15B
Equity Average (Quarter)	0.03B	0.07B	0.15B	0.14B	0.12B	0.10B	0.08B	0.07B	0.07B	0.06B	0.05B	0.05B
Invested Capital (Quarter)	0.00B	0.16B	0.17B	0.18B	0.16B	0.13B	0.07B	0.08B	0.07B	0.06B	0.05B	0.06B				0.11B				0.07B
Asset Utilization Ratio (Quarter)					0.01	0.02	0.02	0.03	0.02	0.02	0.03	0.05
Leverage & Solvency
Debt to Equity (Quarter)	0.33	0.14	0.14	0.39	0.38	0.43	0.07	0.10	0.07	0.07	0.06	0.10				0.05				0.10
Debt Ratio (Quarter)	0.00	0.10	0.09	0.21	0.20	0.21	0.04	0.04	0.02	0.02	0.02	0.03				0.03				0.04
Equity Ratio (Quarter)	0.00	0.73	0.66	0.54	0.53	0.49	0.53	0.39	0.37	0.35	0.33	0.30				0.53				0.44
Valuation
Enterprise Value (Quarter)	-0.09B	-0.09B	-0.17B	-0.22B	-0.21B	-0.17B	-0.19B	-0.10B	-0.15B	-0.14B	-0.13B	-0.13B				-0.16B				-0.11B
Return Ratios
Return on Sales (Quarter)		-0.54%	-0.17%	-0.73%	-0.15%	-0.17%	-0.24%	-0.17%	-0.14%	-0.07%	-0.05%	-0.02%	-0.02%	-0.01%	-0.02%	-0.02%	-0.02%	-0.03%	-0.04%	-0.02%
Return on Capital Employed (Quarter)	-0.08%	-0.10%	-35.79%	-33.17%	-36.01%	-42.12%	-58.47%	-53.96%	-38.80%	-37.31%	-31.37%	-30.05%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	-0.01%	-0.01%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%

Research Tools

ProQR Therapeutics Ratios (2013-2025) | PRQR

Create an account

Sign In

Reset Password